DelistingJun 12, 2026, 09:12 AM
BiomX Plan to Regain NYSE American Compliance Accepted Until Sep 2027
AI Summary
BiomX Inc. announced that NYSE Regulation accepted its plan to regain compliance with the exchange's continued listing standards. The company has been granted a plan period until September 25, 2027, to address its non-compliance, which stemmed from a stockholders' deficit of $(1,302,000) as of December 31, 2025, and sustained losses. While its common stock will continue to trade on NYSE American with a ".BC" indicator, the company acknowledges there are no assurances it will successfully regain compliance within the specified timeframe.
Key Highlights
- NYSE American accepted BiomX's plan to regain compliance with listing standards on June 10, 2026.
- The company was granted a plan period through September 25, 2027, to achieve compliance.
- Non-compliance was due to Sections 1003(a)(i), (ii), and (iii) of the NYSE American LLC Company Guide.
- BiomX reported a stockholders' deficit of $(1,302,000) as of December 31, 2025.
- The company also had losses from continuing operations and/or net losses in its five most recent fiscal years.
- Common stock will continue to be listed and traded on NYSE American with a ".BC" indicator.
- Failure to regain compliance by September 25, 2027, or make satisfactory progress may lead to delisting proceedings.
Price Impact
More from PHGE